Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1
US7932031B2 · kind B2 · utility
11Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2007 |
| Grant date | Apr 26, 2011 |
| Priority date | — |
| Expiry date | Oct 1, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Biomarkers that are useful for identifying a mammal that will respond therapeutically or is responding therapeutically to a method of treating cancer that comprises administering a microtubule-stabilizing agent. In one aspect, the cancer is breast cancer, and the microtubule-stabilizing agent is an epothilone or analog or derivative thereof, or ixabepilone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.